Literature DB >> 15389932

NMR analysis of neutrophil activation in sputum samples from patients with cystic fibrosis.

Erik J Saude1, Paige Lacy, Sorin Musat-Marcu, Damon C Mayes, John Bagu, S F Paul Man, Brian D Sykes, Redwan Moqbel.   

Abstract

Disorders of the respiratory system, such as cystic fibrosis (CF), involve the infiltration and activation of airway inflammatory cells, including neutrophils. This leads to the secretion of peroxidases, which react further with substrates in solution to produce oxidative metabolites, such as 3-chlorotyrosine. Elevated levels of modified tyrosine residues in the airways of patients with CF may be detectable by nuclear magnetic resonance (NMR) in correlation with inflammatory cell influx. In this study, high-resolution (500 MHz) 1H NMR was used to analyze the production of modified tyrosine residues resulting from in vitro stimulation of peripheral blood eosinophils and neutrophils, as well as in sputum samples from control subjects and patients with CF. Following in vitro stimulation, purified peripheral blood neutrophils generated 3-chlorotyrosine, while eosinophils produced predominantly 3-bromotyrosine and 3,5-dibromotyrosine. Chlorinated and brominated tyrosine residues were detected in sputum samples from patients with CF (N=7), but were not detected in the control group (N=9). Neutrophil counts in CF sputum correlated strongly with the presence of 3-chlorotyrosine (r2=0.869). Our findings indicate that neutrophil and eosinophil activation in CF is detectable by NMR. NMR may be a useful tool for the detection of biological markers of inflammatory processes in patient airways.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15389932     DOI: 10.1002/mrm.20242

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  5 in total

1.  A metabolomic approach for diagnosis of experimental sepsis.

Authors:  José L Izquierdo-García; Nicolás Nin; Jesús Ruíz-Cabello; Yeny Rojas; Marta de Paula; Sonia López-Cuenca; Luis Morales; Leticia Martínez-Caro; Pilar Fernández-Segoviano; Andrés Esteban; José A Lorente
Journal:  Intensive Care Med       Date:  2011-10-06       Impact factor: 17.440

Review 2.  Proteomic Analysis of Human Sputum for the Diagnosis of Lung Disorders: Where Are We Today?

Authors:  Maura D'Amato; Paolo Iadarola; Simona Viglio
Journal:  Int J Mol Sci       Date:  2022-05-19       Impact factor: 6.208

3.  A halotyrosine antibody that detects increased protein modifications in asthma patients.

Authors:  Hongjun Jin; Teal S Hallstrand; Don S Daly; Melissa M Matzke; Parameswaran Nair; Diana J Bigelow; Joel G Pounds; Richard C Zangar
Journal:  J Immunol Methods       Date:  2013-12-02       Impact factor: 2.303

4.  Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.

Authors:  Jun Yang; Jason P Eiserich; Carroll E Cross; Brian M Morrissey; Bruce D Hammock
Journal:  Free Radic Biol Med       Date:  2012-05-08       Impact factor: 7.376

5.  Sputum analysis in diagnosis and management of obstructive airway diseases.

Authors:  Paige Lacy; Jennifer L Lee; Dilini Vethanayagam
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.